The US market accounts for close to 50 percent of Granules' total revenue. The executive director of Granules Pharmaceuticals talks about the challenges of working in that market and how they are dealing with increasing pricing pressures
Priyanka Chigurupati, executive director of Granules Pharmaceuticals